<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8">

  <title>NICE Formulary - HYDROCORTISONE</title>

  <meta name="X-UA-Compatible" content="IE=edge,chrome=1">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0">
  <meta name="description" content="">
  <meta name="author" content="NICE - The National Institute of Health and Care Excellence">

  <!--[if lt IE 9]>
  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/html5shiv.js"></script>
  <![endif]-->

  <!-- Le styles -->
  <link rel="stylesheet" href="http://mattonfoot.github.io/NICE.UI/styles/ui.css">

  <!-- Fav and touch icons -->
  <link rel="shortcut icon" href="http://cdn.nice.org.uk/V3/Content/nice/favicon.ico">
  <link rel="apple-touch-icon-precomposed" href="http://cdn.nice.org.uk/V3/Content/nice/favicon-152.png">
  <meta name="msapplication-TileColor" content="#fafafb">
  <meta name="msapplication-TileImage" content="http://cdn.nice.org.uk/V3/Content/nice/favicon-144.png">

  <style>
  .tab-content {
    overflow: auto;
  }
  .tab-content > .tab-pane {
    display: none;
  }
  .tab-content > .active {
    display: block;
  }

  header .nav {
    list-style: decimal inside none;
  }
  header .nav > li {
    display: list-item;
  }
  header .nav > li > a {
    display: block;
    margin: 0;
    padding: 0;
    text-decoration: none;
    color: #01769d;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus,
  header .nav > li.active > a,
  header .nav > li.active > a:hover,
  header .nav > li.active > a:focus {
    outline: 0;
    color: #08455b;
    background: transparent;
    text-decoration: none;
  }
  header .nav > li > a:hover,
  header .nav > li > a:focus {
    text-decoration: underline;
  }

  [outputclass="title"],
  .title {
    font-size: 19px;
    font-size: 1.9rem;
    line-height: 24px;
    line-height: 2.4rem;
  }

  h3, h4, h5, h6, .title, [outputclass="title"] {
    margin-bottom: 0;
  }

  h1+p, h2+p, h3+p, h4+p, h5+p, h6+p, .title+p, [outputclass="title"]+p {
    margin-top: 0;
  }

  .doses {
    padding-left: 0;
    list-style: none;
  }
  .doses .dose {
    padding-left: 24px;
    padding-left: 2.4rem;
    margin-bottom: 6px;
    margin-bottom: .6rem;
  }
  .doses .adult {
    border-left: 7px solid #346e7f;
  }
  .doses .child {
    border-left: 7px solid #82176F;
  }

  /* DITA symbols */

  ph {
    color: #006;
  }

  tm::before {
    font-size: .8em;
    margin-left: -.2em;
    vertical-align: top;
  }
  tm[tmtype="reg"]::before {
    content: "\00ae";
  }
  tm[tmtype="copy"]::before {
    content: "\00a9";
  }
  tm[tmtype="trade"]::before {
    content: "\2122";
  }

  </style>
</head>

<body id="" class="">
  <header>
    <div class="container">
      <ul class="breadcrumb">
        <li><a href="../">Home</a> <span class="divider glyph-chevron-right"></span></li>
        <li class="active"><a href="../drug/">Drugs</a></li>
      </ul>

      <h1>HYDROCORTISONE</h1>

        <p><a href="../drugClass/PHP34623.html">CORTICOSTEROIDS (SYSTEMIC)</a><a href="../drugClass/PHP34550.html">CORTICOSTEROIDS (TOPICAL)</a></p>

      <nav>
        <ul class="nav nav-list">

          <li class="active"><a href="#indicationsAndDoses" data-toggle="tab">Indications and doses</a></li>
          <li><a href="#contraindications" data-toggle="tab">Contra indications</a></li>
          <li><a href="#sideEffects" data-toggle="tab">Side effects</a></li>
          <li><a href="#directionsForAdministration" data-toggle="tab">Administration</a></li>
          <li><a href="#patientAndCarerAdvice" data-toggle="tab">Patient and carer advice</a></li>
          <li><a href="#cautions" data-toggle="tab">Cautions</a></li>
          <li><a href="#unlicensedUse" data-toggle="tab">Unlicensed use</a></li>
          <li><a href="#prescribingAndDispensingInformation" data-toggle="tab">Prescribing and dispensing</a></li>
          <li><a href="#lessSuitableForPrescribing" data-toggle="tab">Less suitable for prescribing</a></li>
          <li><a href="#professionSpecificInformation" data-toggle="tab">Profession specific information</a></li>
          <li><a href="#exceptionsToLegalCategory" data-toggle="tab">Exceptions to legal category</a></li>
          <li><a href="#medicinalForms" data-toggle="tab">Medicinal forms</a></li>
        </ul>
      </nav>

      <br/>
    </div>
  </header>

  <div class="container">
    <div class="tab-content">

      <section class="tab-pane active" id="indicationsAndDoses">
        <h2>Indications and doses</h2>

        <section class="indicationAndDoseGroups">
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Thyrotoxic crisis (thyroid storm)</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100 mg every 6 hours, to be administered as sodium succinate.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Adrenocortical insufficiency resulting from septic shock</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                50 mg every 6 hours, given in combination with fludrocortisone.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute hypersensitivity reactions such as angioedema of the upper respiratory tract and anaphylaxis (adjunct to adrenaline)</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100&#8211;300 mg, to be administered as sodium succinate.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Corticosteroid replacement, in patients who have taken more than 10&#8239;mg prednisolone daily (or equivalent) within 3 months of minor surgery under general anaesthesia</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection or by intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 25&#8211;50 mg, to be administered at induction of surgery, the patient's usual oral corticosteroid dose is recommenced after surgery.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Corticosteroid replacement, in patients who have taken more than 10&#8239;mg prednisolone daily (or equivalent) within 3 months of moderate or major surgery</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection or by intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 25&#8211;50 mg, to be administered at induction of surgery (following usual oral corticosteroid dose on the morning of surgery), followed by 25&#8211;50 mg 3 times a day for 24 hours after moderate surgery and for 48&#8211;72 hours after major surgery.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Adrenocortical insufficiency in Addison&#8217;s disease or following adrenalectomy</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth using immediate-release medicines</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                20&#8211;30 mg daily in 2 divided doses, the larger dose to be given in the morning and the smaller in the evening, mimicking the normal diurnal rhythm of cortisol secretion, the optimum daily dose is determined on the basis of clinical response.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Adrenocortical insufficiency</span>,
            </h4>
            <p class="specificity"><span class="route">By intramuscular injection or by slow intravenous injection or by intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100&#8211;500 mg 3&#8211;4 times a day or when required.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Severe inflammatory bowel disease</span>,
            </h4>
            <p class="specificity"><span class="route">By slow intravenous injection or by intravenous infusion</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100&#8211;500 mg 3&#8211;4 times a day or when required.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Replacement in adrenocortical insufficiency</span>,
            </h4>
            <p class="specificity"><span class="route">By mouth using immediate-release medicines</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                20&#8211;30 mg once daily, adjusted according to response, dose to be taken in the morning.</li>
              <li class="dose adult"><strong>For adults </strong><br/>
                20&#8211;30 mg daily in divided doses, adjusted according to response.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Ulcerative colitis</span>,
                <span class="indication">Proctitis</span>,
                <span class="indication">Proctosigmoiditis</span>,
            </h4>
            <p class="specificity"><span class="route">By rectum using rectal foam</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Initially 1 metered application 1&#8211;2 times a day for 2&#8211;3 weeks, then reduced to 1 metered application once daily on alternate days, to be inserted into the rectum.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Acute hypersensitivity reactions</span>,
                <span class="indication">Angioedema</span>,
            </h4>
            <p class="specificity"><span class="route">By intramuscular injection or by intravenous injection</span></p>
            <ul class="doses">
              <li class="dose child"><strong>For children 1&#8211;5 months</strong><br/>
                Initially 25 mg 3 times a day, adjusted according to response.</li>
              <li class="dose child"><strong>For children 6 months&#8211;5 years</strong><br/>
                Initially 50 mg 3 times a day, adjusted according to response.</li>
              <li class="dose child"><strong>For children 6&#8211;11 years</strong><br/>
                Initially 100 mg 3 times a day, adjusted according to response.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                Initially 200 mg 3 times a day, adjusted according to response.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Mild inflammatory skin disorders such as eczemas</span>,
            </h4>
            <p class="specificity"><span class="route">To the skin</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                Apply 1&#8211;2 times a day, to be applied thinly.</li>
              <li class="dose child"><strong>For children </strong><br/>
                Apply 1&#8211;2 times a day, to be applied thinly.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Nappy rash</span>,
            </h4>
            <p class="specificity"><span class="route">To the skin</span></p>
            <ul class="doses">
              <li class="dose child"><strong>For children </strong><br/>
                Apply as required for no more than 1 week, discontinued as soon as the inflammation subsides.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Severe acute asthma</span>,
                <span class="indication">Life-threatening acute asthma</span>,
            </h4>
            <p class="specificity"><span class="route">By intravenous injection</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                100 mg every 6 hours until conversion to oral prednisolone is possible, dose given, preferably, as sodium succinate.</li>
              <li class="dose child"><strong>For children 1 month&#8211;1 year</strong><br/>
                4 mg/kg every 6 hours (max. per dose 100 mg), alternatively 25 mg every 6 hours until conversion to oral prednisolone is possible, dose given, preferably, as sodium succinate.</li>
              <li class="dose child"><strong>For children 2&#8211;4 years</strong><br/>
                4 mg/kg every 6 hours (max. per dose 100 mg), alternatively 50 mg every 6 hours until conversion to oral prednisolone is possible, dose given, preferably, as sodium succinate.</li>
              <li class="dose child"><strong>For children 5&#8211;11 years</strong><br/>
                4 mg/kg every 6 hours (max. per dose 100 mg), alternatively 100 mg every 6 hours until conversion to oral prednisolone is possible, dose given, preferably, as sodium succinate.</li>
            </ul>
          </section>
          <section class="indicationAndDoseGroup">
            <h4 class="indications">
                <span class="indication">Oral and perioral lesions</span>,
            </h4>
            <p class="specificity"><span class="route">By buccal administration</span></p>
            <ul class="doses">
              <li class="dose adult"><strong>For adults </strong><br/>
                1 lozenge 4 times a day, allowed to dissolve slowly in the mouth in contact with the ulcer.</li>
              <li class="dose child"><strong>For children 1 month&#8211;11 years</strong><br/>
                Only on medical advice.</li>
              <li class="dose child"><strong>For children 12&#8211;17 years</strong><br/>
                1 lozenge 4 times a day, allowed to dissolve slowly in the mouth in contact with the ulcer.</li>
            </ul>
          </section>
        </section>
        
        
            <section class="doseEquivalence">
                <h3>Dose equivalence and conversion</h3>
              <p>When switching from immediate-release hydrocortisone tablets to modified release <i>Plenadren</i>
            <tm tmtype="reg"/> use same total daily dose. Bioavailability of <i>Plenadren</i>
            <tm tmtype="reg"/> lower than immediate release tablets&#8212;monitor clinical response.</p>
            </section>
        
        
        
            <section class="potency">
              <h3>Potency of preperations</h3>
              <p>Hydrocortisone cream and ointment 0.5 to 2.5%: mild</p>
            </section>
      </section>






      <section class="tab-pane" id="contraindications">
        <h2>Contra indications</h2>

      </section>

      <section class="tab-pane" id="sideEffects">
        <h2>Known side effects</h2>

        
          <h3>Specific side effects</h3>
              <p>
                <strong>notKnown:</strong> local sensitivity reactions, phosphate ester associated with pain and paraesthesia (particularly in the perineal region), candidal infection, exacerbation of local infection, local irritation,
              </p>
        
        
      </section>

      <section class="tab-pane" id="directionsForAdministration">
        <h2>Directions for administration</h2>

            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in children</h3>
              <p>For <i>intravenous administration</i>, dilute with Glucose 5% or Sodium Chloride 0.9%.</p><p>For <i>intermittent infusion</i> give over 20&#8211;30 minutes.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">oral</ph> use in children</h3>
              <p>For administration <i>by mouth</i>, injection solution may be swallowed [unlicensed use] but consider phosphate content.</p><p>Alternatively <i>Corlan </i>
            <tm tmtype="reg"/> pellets may be swallowed [unlicensed use]&#8212;pellets should not be cut as may not provide appropriate dose.</p>
            </section>
            <section class="directionsForAdministration">
              <h3 class="specificity">With <ph outputclass="route">intravenous</ph> use in adults</h3>
              <p>For <i>intravenous infusion</i> (as sodium succinate) (<i>SoluCortef</i>
            <tm tmtype="reg"/>), give continuously <i>or</i> intermittently <i>or via</i> drip tubing <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%.</p>
            </section>
      </section>

      <section class="tab-pane" id="patientAndCarerAdvice">
        <h2>Advice for patients and carers</h2>

            <section class="generalPatientAdvice">
              <h3 class="specificity">With <ph outputclass="route">systemic</ph> use</h3>
              <p>Patient counselling is advised for hydrocortisone tablets and injections (steroid card).</p>
            </section>
            <section class="generalPatientAdvice">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use</h3>
              <p>Patient counselling is advised for hydrocortisone cream and ointment (application).</p>
            </section>
      </section>



      <section class="tab-pane" id="cautions">
        <h2>Cautions regarding administration</h2>

        <ul>
          <li>
              <strong>When used by ear:</strong>
            avoid prolonged use
          </li>
          <li>
              <strong>With rectal use:</strong>
            systemic absorption may occur
          </li>
        </ul>
      </section>



      <section class="tab-pane" id="unlicensedUse">
        <h2>Unlicensed use</h2>

            <section class="unlicensedUse">
              <h3 class="specificity">With <ph outputclass="route">buccal</ph> use in children</h3>
              <p>
            <i>Hydrocortisone mucoadhesive buccal tablets</i> licensed for use in children (under 12 years&#8212;on medical advice only).</p>
            </section>
            <section class="unlicensedUse">
              <p>Use of injection by mouth is unlicensed.</p><p>Systemic use of <i>Corlan</i>
            <tm tmtype="reg"/> pellets is unlicensed.</p>
            </section>
      </section>

      <section class="tab-pane" id="prescribingAndDispensingInformation">
        <h2>Information regarding prescribing and dispensing</h2>

            <section class="prescribingAndDispensingInformation">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use</h3>
              <p>When hydrocortisone cream or ointment is prescribed and no strength is stated, the 1% strength should be supplied.</p>
            </section>
      </section>



      <section class="tab-pane" id="lessSuitableForPrescribing">
        <h2>Conditions when less suitable for prescribing</h2>

            <section class="lessSuitableForPrescribing">
              <p>Hydrocortisone as the sodium phosphate is less suitable for prescribing as paraesthesia and pain (particularly in the perineal region) may follow intravenous injection.</p>
            </section>
      </section>



      <section class="tab-pane" id="professionSpecificInformation">
        <h2>Profession specific information</h2>

          <h3>Dental practitioners</h3>
        
            <section class="dentalPractitionersFormulary">
              <h3 class="specificity">With <ph outputclass="route">buccal</ph> use</h3>
              <p>Mucoadhesive buccal tablets may be prescribed as Hydrocortisone Oromucosal Tablets.</p>
            </section>
            <section class="dentalPractitionersFormulary">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use</h3>
              <p>Hydrocortisone Cream 1% 15&#8239;g may be prescribed.</p>
            </section>
      </section>

      <section class="tab-pane" id="exceptionsToLegalCategory">
        <h2>Exceptions to legal category</h2>

            <section class="exceptionsToLegalCategory">
              <h3 class="specificity">With <ph outputclass="route">intramuscular</ph> use or <ph outputclass="route">intravenous</ph> use</h3>
              <p>Prescription only medicine restriction does not apply where administration is for saving life in emergency.</p>
            </section>
            <section class="exceptionsToLegalCategory">
              <h3 class="specificity">With <ph outputclass="route">topical</ph> use</h3>
                <p class="title">Over-the-counter hydrocortisone preparations</p>
              <p>Skin creams and ointments containing hydrocortisone (alone or with other ingredients) can be sold to the public for the treatment of allergic contact dermatitis, irritant dermatitis, insect bite reactions and mild to moderate eczema in patients over 10 years, to be applied sparingly over the affected area 1&#8211;2 times daily for max. 1 week. Over-the-counter hydrocortisone preparations should not be sold without medical advice for children under 10 years or for pregnant women; they should <b>not</b> be sold for application to the face, anogenital region, broken or infected skin (including cold sores, acne, and athlete&#8217;s foot).</p>
            </section>
      </section>


      <section class="tab-pane" id="medicinalForms">
        <h2>Prepared medicinal forms of HYDROCORTISONE</h2>


            <section class="licensingVariationStatement">
              <p>There can be variation in the licensing of different medicines containing the same drug.</p>
            </section>
        
          <strong>Forms available from special-order manufacturers include: </strong>
            suppository,
            oral suspension,
            oral solution,
            capsule,
            eye ointment,
            liquid,
            pastille,

            <div id="PHP77061"><a href="../medicinalForm/PHP77061.html" data-target="#PHP77061" data-action="load">Tablet</a></div>
            <div id="PHP77298"><a href="../medicinalForm/PHP77298.html" data-target="#PHP77298" data-action="load">Muco-adhesive buccal tablet</a></div>
            <div id="PHP75353"><a href="../medicinalForm/PHP75353.html" data-target="#PHP75353" data-action="load">Modified-release tablet</a></div>
            <div id="PHP74760"><a href="../medicinalForm/PHP74760.html" data-target="#PHP74760" data-action="load">Solution for injection</a></div>
            <div id="PHP74979"><a href="../medicinalForm/PHP74979.html" data-target="#PHP74979" data-action="load">Powder for solution for injection</a></div>
            <div id="PHP74612"><a href="../medicinalForm/PHP74612.html" data-target="#PHP74612" data-action="load">Powder and solvent for solution for injection</a></div>
            <div id="PHP77140"><a href="../medicinalForm/PHP77140.html" data-target="#PHP77140" data-action="load">Suspension for injection</a></div>
            <div id="PHP77215"><a href="../medicinalForm/PHP77215.html" data-target="#PHP77215" data-action="load">Foam</a></div>
            <div id="PHP74834"><a href="../medicinalForm/PHP74834.html" data-target="#PHP74834" data-action="load">Cream</a></div>
            <div id="PHP74909"><a href="../medicinalForm/PHP74909.html" data-target="#PHP74909" data-action="load">Ointment</a></div>
      </section>
    </div>
  </div>

  <script src="http://mattonfoot.github.io/NICE.UI/scripts/vendor/jquery.js"></script>
  <script src="http://cdn.nice.org.uk/V3/Scripts/twitter.bootstrap.js"></script>
  <script src="/content/scripts/NICE.RemoteLoad.js"></script>
</html>
